MiR-22 as a metabolic silencer and liver tumor suppressor-Reference-Cited by-同舟云学术

MiR-22 as a metabolic silencer and liver tumor suppressor

Published:2020-06 Issue:2 Volume:4 Page:74-80
ISSN:2542-5684
Container-title:Liver Research
language:en
Short-container-title:Liver Research

Author:

Wang Lijun,Wang Yu-Shiuan,Mugiyanto Eko,Chang Wei-Chiao,Wan Yu-Jui Yvonne

Funder

National Institutes of Health

UC Davis Comprehensive Cancer Center

UC Davis Global Affairs seed

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference57 articles.

1. miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer;Chen;Canc Lett,2015

2. miR-22 in cardiac remodeling and disease;Huang;Trends Cardiovasc Med,2014

3. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22;Feng;PloS One,2014

4. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma;Shi;Biomed Pharmacother,2013

5. Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review);Wang;Int J Oncol,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy;Non-coding RNA Research;2024-12

2. Review of the Different Outcomes Produced by Genetic Knock Out of the Long Non-coding microRNA-host-gene MIR22HG versus Pharmacologic Antagonism of its Intragenic microRNA product miR-22-3p;MicroRNA;2024-06-28

3. MicroRNA-22-3p displaces critical host factors from the 5′ UTR and inhibits the translation of Coxsackievirus B3 RNA;Journal of Virology;2024-02-20

4. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors;Biomedicines;2023-10-12

5. miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism;Molecular Therapy;2023-06